Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dejardin

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biostatistics (Oxford, England)|June 4, 2013
Stochastic EM algorithm for doubly interval-censored dataDavid Dejardin, Emmanuel Lesaffre
Statistics in Medicine|June 24, 2010
Joint modeling of progression-free survival and death in advanced cancer clinical trialsDavid Dejardin, Emmanuel Lesaffre, Geert Verbeke
Pharmaceutical Statistics|April 10, 2014
A randomized phase I Bayesian dose escalation design for the combination of anti-cancer drugsDavid Dejardin, Emmanuel Lesaffre, Paul Hamberg, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world dataWeiQing Venus So, David Dejardin, Eva Rossmann, et al.
Statistics in Medicine|October 26, 2018
Modified power prior with multiple historical trials for binary endpointsAkalu Banbeta, Joost van Rosmalen, David Dejardin, et al.
Frontiers in Immunology|September 5, 2024
An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapiesDavid Dejardin, Anton Kraxner, Emilie Schindler, et al.
Biometrical Journal. Biometrische Zeitschrift|July 17, 2019
A multistate model for early decision-making in oncologyUlrich Beyer, David Dejardin, Matthias Meller, et al.
Statistical Methods in Medical Research|March 22, 2017
Including historical data in the analysis of clinical trials: Is it worth the effort?Joost van Rosmalen, David Dejardin, Yvette van Norden, et al.
Pharmaceutical Statistics|December 29, 2017
Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspectsDavid Dejardin, Paul Delmar, Charles Warne, et al.
Lifetime Data Analysis|September 21, 2025
Bayesian generalized method of moments applied to pseudo-observations in survival analysisLéa Orsini, Caroline Brard, Emmanuel Lesaffre, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biostatistics (Oxford, England)|June 4, 2013
Stochastic EM algorithm for doubly interval-censored dataDavid Dejardin, Emmanuel Lesaffre
Statistics in Medicine|June 24, 2010
Joint modeling of progression-free survival and death in advanced cancer clinical trialsDavid Dejardin, Emmanuel Lesaffre, Geert Verbeke
Pharmaceutical Statistics|April 10, 2014
A randomized phase I Bayesian dose escalation design for the combination of anti-cancer drugsDavid Dejardin, Emmanuel Lesaffre, Paul Hamberg, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world dataWeiQing Venus So, David Dejardin, Eva Rossmann, et al.
Statistics in Medicine|October 26, 2018
Modified power prior with multiple historical trials for binary endpointsAkalu Banbeta, Joost van Rosmalen, David Dejardin, et al.
Frontiers in Immunology|September 5, 2024
An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapiesDavid Dejardin, Anton Kraxner, Emilie Schindler, et al.
Biometrical Journal. Biometrische Zeitschrift|July 17, 2019
A multistate model for early decision-making in oncologyUlrich Beyer, David Dejardin, Matthias Meller, et al.
Statistical Methods in Medical Research|March 22, 2017
Including historical data in the analysis of clinical trials: Is it worth the effort?Joost van Rosmalen, David Dejardin, Yvette van Norden, et al.
Pharmaceutical Statistics|December 29, 2017
Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspectsDavid Dejardin, Paul Delmar, Charles Warne, et al.
Lifetime Data Analysis|September 21, 2025
Bayesian generalized method of moments applied to pseudo-observations in survival analysisLéa Orsini, Caroline Brard, Emmanuel Lesaffre, et al.
Pageof 3